 |
|
|
| |
The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort
|
| |
| |
Reported by Jules Levin
EASL 2019 April 10-14 Vienna
Janjua NZ1,2,Wong S,1,3Rossi C1,3, Darvishian M1, 2, Yu A1, Butt ZA1, 2,Yoshida EM,4Ramji A,4Feld J,5Binka M1, Bartlett S1,3, Pearce M1,2, Alvarez M1, Samji H1, Tyndall M1,2, KrajdenM1,3, The BC-HTC Team*
1BC Centre for Disease Control, Vancouver, BC; 2School of Population and Public Health;3 Dept. of Pathology and Laboratory Medicine, 4 Division of Gastroenterology University of British Columbia, Vancouver,BC, Canada, 5Toronto Centre for Liver Disease, Toronto, Canada
|
| |
|
|
|
|
|
